Notable that one of the leading physician advocates for using ivermectin for COVID-19, Paul Marik, was once also convinced that he had cured sepsis with a combination of vitamins and steroids — a finding not replicated once a randomized trial was actually performed.

/Thread
His words: "We haven't seen a patient die of sepsis since we began using the combination therapy a year ago. We have completely changed the natural history of sepsis."

nbc12.com/story/34986689…
He's a member of the FLCCC Alliance, along with Pierre Kory, who testified in the Senate for Ron Johnson that Ivermectin is "effectively a 'miracle drug' against COVID-19."

Ivermectin is not the only FLCCC Alliance's recommendation that is not evidenced-based.
For instance, here's their "Long COVID" protocol, which calls for treatment (on the basis of little to no evidence) with:
-Ivermectin
-Steroids
-"Treatment of Suspected Mast Cell Activation" (various agents)
-"Macrophage/Monocyte Repolarization Therapy"
(various agents) Image
One can disagree about role that social media companies should (or shouldn't) play in censoring misinformation — I fall more on the ACLU end of the spectrum — but the push by @BretWeinstein & others to cast ivermectin as a suppressed miracle cure is goofy, and indeed harmful.
A large, high-quality trial can be conducted. If benefit is demonstrated (and a priori that's improbable with such a re-purposed drug), that would be wonderful! But based on where things stand now, these individuals, including critical care doctors, are making extraordinary, ...
... indeed grandiose claims that is simply not backed by adequate evidence, both for ivermectin and their "protocols" more broadly. It's grossly irresponsible.
It's not at all surprising that this happened- earlier with hydroxychloroquine and now with ivermectin. The "allure of the miracle cure" exerts such a strong pull - both patients and physicians are potentially prone to perceive such a cure based on narrow reading, or experience
... even if motives are the best (they aren't always).

One takeaway is that we need a broader public understanding of why we need high-quality, randomized clinical trials with hard endpoints before approving / using the vast majority of drugs...
There's a general sense that the direct observations of physicians ("My patients got better!") or patients ("I felt better!") is powerful evidence of efficacy. That's understandable, but it isn't: frequently such observations suggest efficacy for drugs that are useless or harmful
The reality is that we are all prone to excessive belief in what our own observations and experiences reveal about cause-and-effect relationships — it's not a sign of an intellectual deficit but just the fundamental, invariable limitations of one particular mode of human inquiry.
Similarly, we can be excessively credulous about physiologic explanations for efficacy, e.g. a molecular hypothesis for why drug X helps disease Y. At issue here is a biased assessment of how fully we understand real-world biological drug effects, which are profoundly complex.
We also inappropriately accept "surrogate outcomes" - lab values or imaging findings that we can track, versus hard outcomes (e.g. death). If Alzheimer's is associated with more amyloid in the brain, and amyloid is bad, and a new drug reduces amyloid levels — isn't that good?
Not necessarily — regardless of the overall correctness of the biological hypothesis. If the drug doesn't also improve either the length or quality of life, who cares what "the levels" do?

Yet the FDA is using such surrogate outcomes for approvals more and more.
Some of these issues didn't matter nearly as much say 100 years ago, except to scientists and physicians perhaps, but with the tremendous rise of medicine as a presence and force in our daily lives — and a major issue in politics and policy — I think that teaching of ...
... these and related issues should perhaps be a part of our basic primary education.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Adam W Gaffney

Adam W Gaffney Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @awgaffney

11 Jun
This article argues that the FDA's approval of Biogen's new expensive Alzheimer's drug could "mark a seismic change in how Medicare thinks about covering new drugs of marginal effectiveness."

But that's not what I want to see come out of this.

Thread.

theatlantic.com/ideas/archive/…
If the FDA approves a drug, and insurers (like Medicare) deny it for whatever reason, the public will feel that a useful therapeutic is being denied to them. Rich people, of course, will still be able to purchase the drug.
Now you may say: OK, but you said this new Alzheimer's drug may be useless, so what's the problem? Well, there are many.

First, desperate families/patients who do whatever they can to purchase it out-of-pocket may be harmed by the ineffective drug.

washingtonpost.com/outlook/2021/0…
Read 10 tweets
4 Apr
One of the most under-emphasized findings of the Oregon Medicaid Experiment was that it found a causal link between lack of health insurance and depression that cannot be explained by lack of access to mental healthcare alone ...

ncbi.nlm.nih.gov/pmc/articles/P…
... Gaining health insurance reduced the rate of depression by about 30% (or 9 percentage points).

The increase in mental health treatment experienced by those newly covered can't fully explain this increase. So what can?
...Well, it should be unsurprising that the uncertainty and profound strain produced by precarity & deprivation would worsen mental health! Alleviating some of that uncertainty might, conversely, help improve mental health.
Read 7 tweets
4 Apr
Some thoughts on this new blog post in @Health_Affairs by Caroline Kelly, @WF_Parker, and @haroldpollack, which raises some very important issues, but which I have some points of disagreement with.

healthaffairs.org/do/10.1377/hbl…
They rightly highlight disparities in resources between hospitals taking care of poor and rich patients — or predominantly white vs. Black patient populations — during the COVID-19 pandemic. They emphasize how such disparities could exacerbate class/racial disparities in outcomes
It's an important issue.  I wrote about such "supply inequity" in COVID-19 last year: resource maldistribution is one more manifestation of Hart's "Inverse Care Law", or idea that availability of healthcare is inversely correlated with the need for it.

thebaffler.com/salvos/bill-of…
Read 14 tweets
19 Mar
Some have posited that seroprevalence studies underestimate population immunity because antibody levels wane over time, and hence implied that this or that area may "already be at herd immunity."

New Wuhan study in the @TheLancet refutes that:
thelancet.com/journals/lance…
This population level seroprevalence study found that only ~7% of the population of Wuhan was seropositive in April, 2020. With repeat measurement up to 9 months later, 90%+ of these individuals were still seropositive.
US seroprevalence estimates from commercial labs summarized by the CDC below (albeit with more methodological issues) suggest that seroprevalence remains relatively low in most US states: in every state, it appears that a majority are still susceptible.

covid.cdc.gov/covid-data-tra…
Read 5 tweets
18 Mar
There’s one question that the new Lancet study on COVID reinfection, which is based on testing data from the entire nation of Denmark and that finds ~80% protection against infection (less among older folks) from prior infection, doesn’t answer ... thelancet.com/journals/lance…
Does prior infection also reduce severity of infection? They don’t present data on whether infections led to hospitalization. However, even had they, there were only 72 instances of reinfection (though data is from all of Denmark!), so may not have been very illuminating ...
However, knowing the answer to that question could shed some light on the question of whether SARS-CoV-2 is destined to become “just another” (i.e. low virulence) circulating coronavirus, or not. Of course, these data do not necessarily apply to immunity from vaccination ...
Read 5 tweets
17 Mar
Very excited to see the re-introduction today of the House Medicare-for-All bill by @RepJayapal and @RepDebDingell — with a majority of House Democrats signed on as co-sponsors.

Medicare for All remains the reform we need today, for multiple reasons:

washingtonpost.com/health/2021/03…
1. Medicare-for-All would rapidly achieve 100% population coverage, at a time when uninsurance rates are on the rise. Numerous studies have demonstrated that lack of health coverage is not only financially ruinous — it can be deadly. We need a reform that covers us *all*.
2. Equally important, this bill would eliminate all copays and deductibles. These payments cause kids with asthma to forgo their inhalers, and women with breast cancer to put off chemotherapy (really). A recent study found that they, too, are deadly. And they are unnecessary.
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(